256 related articles for article (PubMed ID: 34374937)
21. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
[TBL] [Abstract][Full Text] [Related]
22. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
23. KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease.
Salazar GA; Kuwana M; Wu M; Estrada-Y-Martin RM; Ying J; Charles J; Mayes MD; Assassi S
J Rheumatol; 2018 Aug; 45(8):1153-1158. PubMed ID: 29961690
[TBL] [Abstract][Full Text] [Related]
24. Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study.
Assassi S; Shao N; Yin Z; Volkmann ER; Zoz DF; Leonard TB
Medicine (Baltimore); 2022 Aug; 101(32):e29993. PubMed ID: 35960051
[TBL] [Abstract][Full Text] [Related]
25. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
Winstone TA; Assayag D; Wilcox PG; Dunne JV; Hague CJ; Leipsic J; Collard HR; Ryerson CJ
Chest; 2014 Aug; 146(2):422-436. PubMed ID: 24576924
[TBL] [Abstract][Full Text] [Related]
26. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological management of systemic sclerosis associated interstitial lung disease.
Dixon G; Adamali I; Adamali H; Barratt S; Gunarwardena H; Pauling JD
Expert Opin Pharmacother; 2023 May; 24(7):815-824. PubMed ID: 37029594
[TBL] [Abstract][Full Text] [Related]
28. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
[TBL] [Abstract][Full Text] [Related]
29. Use of mycophenolate mofetil for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: Information from a Japanese hospital claims database.
Funatogawa T; Narita Y; Tamura A; Mii K; Sugitani Y; Uchida T
Mod Rheumatol; 2022 Jul; 32(4):755-760. PubMed ID: 34850080
[TBL] [Abstract][Full Text] [Related]
30. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.
Barskova T; Gargani L; Guiducci S; Randone SB; Bruni C; Carnesecchi G; Conforti ML; Porta F; Pignone A; Caramella D; Picano E; Cerinic MM
Ann Rheum Dis; 2013 Mar; 72(3):390-5. PubMed ID: 22589373
[TBL] [Abstract][Full Text] [Related]
31. Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.
Saigusa R; Asano Y; Nakamura K; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Yoshizaki A; Miyazaki M; Tamaki Z; Sato S
Mod Rheumatol; 2017 Jul; 27(4):618-622. PubMed ID: 27538472
[TBL] [Abstract][Full Text] [Related]
32. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
Mugii N; Someya F
Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
[TBL] [Abstract][Full Text] [Related]
33. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease.
Bruni C; Occhipinti M; Pienn M; Camiciottoli G; Bartolucci M; Bosello SL; Payer C; Bálint Z; Larici AR; Tottoli A; Tofani L; De Lorenzis E; Lepri G; Bellando-Randone S; Spinella A; Giuggioli D; Masini F; Cuomo G; Lavorini F; Colagrande S; Olschewski H; Matucci-Cerinic M
Rheumatology (Oxford); 2023 Feb; 62(2):696-706. PubMed ID: 35708639
[TBL] [Abstract][Full Text] [Related]
34. Responses to exercise in systemic sclerosis-associated interstitial lung disease.
Donnelly RP; Smyth AE; Mullan C; Riley MS; Nicholls DP
Clin Physiol Funct Imaging; 2023 Jul; 43(4):253-262. PubMed ID: 36660849
[TBL] [Abstract][Full Text] [Related]
35. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
[TBL] [Abstract][Full Text] [Related]
36. Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease.
Cerro-Chiang G; Ayres M; Rivas A; Romero T; Parker SJ; Mastali M; Elashoff D; Chen P; Van Eyk JE; Wolters PJ; Boin F; Zaman T
Sci Rep; 2023 May; 13(1):8645. PubMed ID: 37244972
[TBL] [Abstract][Full Text] [Related]
37. The clinical and economic burden of systemic sclerosis related interstitial lung disease.
Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hansen D; Patel S; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
Rheumatology (Oxford); 2020 Aug; 59(8):1878-1888. PubMed ID: 31740961
[TBL] [Abstract][Full Text] [Related]
38. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
39. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
40. Study of the Correlation between HRCT Semi-quantitative Scoring, Concentration of Alveolar Nitric Oxide, and Clinical-functional Parameters of Systemic Sclerosis-induced Interstitial Lung Disease.
Hoang-Duc H; Pham-Huy Q; Vu-Minh T; Duong-Quy S
Yale J Biol Med; 2020 Dec; 93(5):657-667. PubMed ID: 33380926
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
